Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Schizophrenia

Free Subscription 01.11.2021 1 Can J Psychiatry 2 Clin Neuropharmacol 1 Clin Pharmacokinet 7 J Clin Psychopharmacol 2 Mol Psychiatry 1 Psychiatr Clin North Am 7 Psychiatry Res 4 Psychol Med 4 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Can J Psychiatry

1. VANDEVELDE A, Metivier L, Dollfus S
   Impact cerebral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrenie : revue systematique des etudes longitudinales en neuroimagerie.
   Can J Psychiatry. 2021;66:683-700.
   PubMed         Abstract available
   
   

   
   Clin Neuropharmacol

2. BELTECZKI Z, Ujvari J, Dome P
   Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature.
   Clin Neuropharmacol. 2021;44:148-153.
   PubMed         Abstract available
   
   
3. OZDEMIR YE, Tanir Y
   Low-Dose Aripiprazole-Induced Nocturnal Enuresis in a 9-Year-Old Boy: A Case Report and the Possible Underlying Mechanism.
   Clin Neuropharmacol. 2021;44:108-109.
   PubMed         Abstract available
   
   

   
   Clin Pharmacokinet

4. SUHAS S, Kumar V, Damodharan D, Sharma P, et al
   Comment on: "Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation".
   Clin Pharmacokinet. 2021;60:1073-1075.
   PubMed        
   
   

   
   J Clin Psychopharmacol

5. DANILEWITZ M, Rafizadeh R, Bousman CA
   Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis: A Case Report.
   J Clin Psychopharmacol. 2021;41:218-220.
   PubMed        
   
   
6. MISAWA F, Fujii Y, Takeuchi H
   Can a 4-Month Tolerability Assessment With Paliperidone Palmitate 1-Monthly Prevent Neuroleptic Malignant Syndrome Associated With the 3-Monthly?: Analysis Based on a Spontaneous Reporting System Database in Japan.
   J Clin Psychopharmacol. 2021;41:206-207.
   PubMed        
   
   
7. KHURRAM SK, Ames M, Muniz J
   Case Report: Valbenazine as a Treatment for Tardive Dyskinesia and Unexpected Antipsychotic Effects.
   J Clin Psychopharmacol. 2021;41:220-221.
   PubMed        
   
   
8. YILDIZ MI, Karacam Dogan M, Mutlu E, Abdullayeva L, et al
   All in One: Clozapine-Associated Acute Pancreatitis With Multiple Organ Involvement.
   J Clin Psychopharmacol. 2021;41:214-216.
   PubMed        
   
   
9. GRIFFIN JM, Woznica E, Gilotra NA, Nucifora FC Jr, et al
   Clozapine-Associated Myocarditis: A Protocol for Monitoring Upon Clozapine Initiation and Recommendations for How to Conduct a Clozapine Rechallenge.
   J Clin Psychopharmacol. 2021;41:180-185.
   PubMed         Abstract available
   
   
10. GROVER S, Naskar C, Chakrabarti S
    Does the Starting of Clozapine Influence Coprescription of Other Medications?: A Study From India.
    J Clin Psychopharmacol. 2021;41:148-154.
    PubMed         Abstract available
    
    
11. REHIMINI S, Goddard KG, Margolese HC
    Exceptionally High Clozapine-Associated Eosinophilia.
    J Clin Psychopharmacol. 2021;41:216-218.
    PubMed        
    
    

    
    Mol Psychiatry

12. CHAN SY, Brady RO, Lewandowski KE, Higgins A, et al
    Dynamic and progressive changes in thalamic functional connectivity over the first five years of psychosis.
    Mol Psychiatry. 2021 Oct 25. pii: 10.1038/s41380-021-01319.
    PubMed         Abstract available
    
    
13. KHADIMALLAH I, Jenni R, Cabungcal JH, Cleusix M, et al
    Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia.
    Mol Psychiatry. 2021 Oct 22. pii: 10.1038/s41380-021-01313.
    PubMed         Abstract available
    
    

    
    Psychiatr Clin North Am

14. GHAZIUDDIN N, Andersen L, Ghaziuddin M
    Catatonia in Patients with Autism Spectrum Disorder.
    Psychiatr Clin North Am. 2021;44:11-22.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

15. VALERIO KE, Jonas KG, Perlman G, Bromet EJ, et al
    A comparison of cognitive performance in the Suffolk County cohort and their unaffected siblings.
    Psychiatry Res. 2021;303:114111.
    PubMed         Abstract available
    
    
16. RABINOWITZ J, Rabinowitz AA
    Outlier-response pattern checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).
    Psychiatry Res. 2021;303:114114.
    PubMed         Abstract available
    
    
17. SARZYNSKA-WAWER J, Wawer A, Pawlak A, Szymanowska J, et al
    Detecting formal thought disorder by deep contextualized word representations.
    Psychiatry Res. 2021;304:114135.
    PubMed         Abstract available
    
    
18. PAWELCZYK A, Lojek E, Radek M, Pawelczyk T, et al
    Prosodic deficits and interpersonal difficulties in patients with schizophrenia.
    Psychiatry Res. 2021;306:114244.
    PubMed         Abstract available
    
    
19. CLAYSON PE, Molina JL, Joshi YB, Thomas ML, et al
    Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia.
    Psychiatry Res. 2021;305:114239.
    PubMed         Abstract available
    
    
20. SANCHEZ MC, Escurriola MF, Sanmartin MIF, Solntseva I, et al
    Cardiovascular disease and mortality in people with schizophrenia or antipsychotic treatment: A cohort study in primary care.
    Psychiatry Res. 2021;306:114233.
    PubMed         Abstract available
    
    
21. LUO X, Zhang L, Zhang J, Chen H, et al
    Changes in the cognitive function of Chinese college students with a clinical high risk of psychosis.
    Psychiatry Res. 2021;305:114242.
    PubMed         Abstract available
    
    

    
    Psychol Med

22. AYESA-ARRIOLA R, Ortiz-Garcia de la Foz V, Martinez-Garcia O, Setien-Suero E, et al
    Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort.
    Psychol Med. 2021;51:264-277.
    PubMed         Abstract available
    
    
23. ODUOLA S, Das-Munshi J, Bourque F, Gayer-Anderson C, et al
    Change in incidence rates for psychosis in different ethnic groups in south London: findings from the Clinical Record Interactive Search-First Episode Psychosis (CRIS-FEP) study.
    Psychol Med. 2021;51:300-309.
    PubMed         Abstract available
    
    
24. DAVIES SJC, Iwajomo T, de Oliveira C, Versloot J, et al
    The impact of psychiatric and medical comorbidity on the risk of mortality: a population-based analysis.
    Psychol Med. 2021;51:320-328.
    PubMed         Abstract available
    
    
25. VIEIRA S, Gong Q, Scarpazza C, Lui S, et al
    Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis.
    Psychol Med. 2021;51:340-350.
    PubMed         Abstract available
    
    

    
    Schizophr Res

26. SEABURY RD, Bearden CE, Ventura J, Subotnik KL, et al
    Confident memory errors and disrupted reality testing in early psychosis.
    Schizophr Res. 2021;238:170-177.
    PubMed         Abstract available
    
    
27. MESHOLAM-GATELY RI, Varca N, Spitzer C, Parrish EM, et al
    Are we ready for a name change for schizophrenia? A survey of multiple stakeholders.
    Schizophr Res. 2021;238:152-160.
    PubMed         Abstract available
    
    
28. LEATHEM LD, Currin DL, Montoya AK, Karlsgodt KH, et al
    Socioemotional mechanisms of loneliness in subclinical psychosis.
    Schizophr Res. 2021;238:145-151.
    PubMed         Abstract available
    
    
29. KU BS, Addington J, Bearden CE, Cadenhead KS, et al
    Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium.
    Schizophr Res. 2021;238:137-144.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: